Global Nasogastric Tube Market Size, Share, Forecast Report 2024
The global nasogastric tube market size was exhibited at USD 505.30 million in 2023 and is projected to hit around USD 863.13 million by 2033, growing at a CAGR of 5.5% during the forecast period 2024 to 2033.
Key Takeaways:
A nasogastric tube (NG) is used to enter the stomach through the nostrils, nasopharynx, and throat. It is a flexible tube with bidirectional potential composed of plastic and elastic. These devices can be used for enteral feeding for up to six weeks. Furthermore, the use of NG tubes is frequently prompted by the need to administer medicine and nutrients, add contrast to the stomach for X-rays, remove air or liquids from the stomach, as well as protect the bowel after surgery or while on bowel rest. Thus, propelling the market growth.
Nasogastric Tube Market: Overview
The nasogastric tube market is experiencing significant growth and evolution driven by advancements in medical technology, increasing prevalence of gastrointestinal disorders, and rising demand for enteral feeding solutions. Nasogastric tubes, commonly used in medical settings for enteral feeding, medication administration, and gastric decompression, play a pivotal role in patient care across various healthcare settings.
Nasogastric Tube Market Growth
The growth of the nasogastric tube market is influenced by several key factors. Firstly, the increasing prevalence of gastrointestinal disorders, including digestive system diseases and malnutrition, drives the demand for nasogastric tubes for enteral feeding and medication delivery. Secondly, advancements in tube design and material technology, such as anti-clogging mechanisms and softer materials for enhanced patient comfort, contribute to market expansion. Thirdly, the rising adoption of nasogastric tubes in various healthcare facilities, including hospitals, ambulatory surgical centers, and home healthcare settings, further propels market growth. Additionally, the growing geriatric population worldwide, coupled with the associated rise in chronic diseases requiring enteral feeding support, serves as a significant growth driver for the nasogastric tube market. Overall, these factors collectively contribute to the sustained growth and development of the nasogastric tube market, offering opportunities for manufacturers, healthcare providers, and stakeholders in the medical industry.
Nasogastric Tube Market Report Scope
| Report Coverage | Details |
| Market Size in 2024 | USD 505.30 Million |
| Market Size by 2033 | USD 863.13 Million |
| Growth Rate From 2024 to 2033 | CAGR of 5.5% |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Segments Covered | Patient Type, Indication, Type, End-use, Region |
| Market Analysis (Terms Used) | Value (US$ Million/Billion) or (Volume/Units) |
| Regional Scope | North America; Europe; Asia Pacific; Central and South America; the Middle East and Africa |
| Key Companies Profiled | BD; QMD; Angiplast Pvt. Ltd.; Securmed; Vygon; Medtronic; Andersen Products Inc.; Cardinal Health; Poly Medicure Limited; Baihe Medical. |
Nasogastric Tube Market Dynamics
The nasogastric tube market is witnessing significant growth due to the increasing prevalence of gastrointestinal disorders globally. Conditions such as gastrointestinal cancers, digestive system disorders, and malnutrition necessitate the use of nasogastric tubes for enteral feeding, medication administration, and gastric decompression. This rising incidence of gastrointestinal ailments fuels the demand for nasogastric tubes as essential medical devices, contributing to market expansion.
Technological innovations have revolutionized nasogastric tube design and material technology, driving market growth. Manufacturers are developing tubes with features like anti-clogging mechanisms, radiopaque properties for accurate placement, and softer materials to enhance patient comfort. These advancements improve the efficacy and safety of nasogastric tubes, making them more appealing to healthcare providers and patients alike. As a result, the market experiences increased adoption of nasogastric tubes across various healthcare settings, further boosting its growth trajectory.
Nasogastric Tube Market Restraint
Despite their widespread use, nasogastric tubes carry a risk of complications and adverse events. Improper placement or insertion technique can lead to complications such as nasal mucosal injury, aspiration pneumonia, tube dislodgement, and tube-related infections. These complications not only pose risks to patient safety but also result in additional healthcare costs and potential legal liabilities for healthcare providers.
Nasogastric tubes can cause discomfort and distress to patients, particularly during insertion and while in place. Patients may experience nasal irritation, sore throat, nausea, and vomiting, leading to reduced tolerance and compliance with tube feeding regimens. Additionally, psychological factors such as anxiety and fear associated with nasogastric tube placement can further contribute to patient discomfort and non-compliance. Healthcare providers must address these challenges by implementing strategies to minimize patient discomfort, enhance education and support for patients undergoing nasogastric tube placement, and explore alternative enteral feeding methods where appropriate.
Nasogastric Tube Market Opportunity
The nasogastric tube market stands to benefit from demographic trends, particularly the aging population and the associated rise in chronic diseases. As the elderly population grows globally, the prevalence of conditions requiring enteral feeding support, such as dysphagia, stroke, and neurodegenerative diseases, is expected to increase. This demographic shift presents a significant opportunity for nasogastric tube manufacturers to expand their market presence and cater to the growing demand for enteral feeding solutions.
The nasogastric tube market is ripe for technological advancements and product innovation. Manufacturers are investing in research and development to enhance the safety, efficacy, and patient comfort of nasogastric tubes through innovations in design, materials, and functionalities. For instance, the development of nasogastric tubes with advanced features such as anti-clogging mechanisms, radiopaque properties, and integrated sensors for real-time monitoring represents a promising opportunity to meet the evolving needs of healthcare providers and patients. Moreover, the integration of digital health technologies, such as telemonitoring and smart feeding pumps, offers new avenues for improving the management and delivery of enteral nutrition, creating opportunities for market growth and differentiation.
Nasogastric Tube Market Challenges
.One of the primary challenges in the nasogastric tube market is ensuring regulatory compliance and maintaining high standards of quality assurance. Nasogastric tubes are classified as medical devices and are subject to stringent regulations and standards imposed by regulatory authorities such as the FDA (Food and Drug Administration) in the United States and the CE Marking in Europe. Manufacturers must navigate complex regulatory requirements, including product testing, certification, and documentation, to ensure compliance with safety and performance standards.
The nasogastric tube market faces competitive pricing pressures and cost constraints, particularly in price-sensitive healthcare markets. Healthcare providers, including hospitals and long-term care facilities, often prioritize cost containment and seek cost-effective solutions without compromising quality or patient care. As a result, manufacturers may encounter challenges in maintaining profitability and market share while navigating pricing pressures and cost constraints. Moreover, the presence of numerous market players and the commoditization of nasogastric tubes further intensify competitive dynamics, compelling manufacturers to innovate, differentiate their products, and streamline operations to remain competitive in the market.
Segments Insights:
Patient Type Insights
The adult segment held the largest share of the market in 2023, with 36.9%. The growing use of nasogastric tubes during surgical procedures is fueling the market's expansion, and it is expected that patient nutrition will be its main driver going forward. The demand for nasogastric tubes is anticipated to increase due to the growing number of adult patients. The major utilization of nasogastric tubes is in elderly patients due to the rising rate of chronic kidney diseases. As per the CDC, in 2021, 15% of adults are estimated to have CKD. Thus, it will fuel the growth of the global market.
On the other hand, the geriatric segment is anticipated to witness the fastest growth from 2023 to 2033 period. One of the main growth-stimulating causes is the rising prevalence of chronic illnesses in the U.S. such as cancer and gastrointestinal (GI) disorders. For instance, a report from the Centers for Disease Control and Prevention in June 2023 reported that the patient age group of 65 years and higher accounted for an average of 58% of all cancer cases and are expected to assist the segment to maintain its dominance during the forecast period.
Indication Insights
The others segment is the fastest-growing segment in the market. It is expected to grow at a CAGR of 7.0% between 2023 and 2033. The World Health Organization (WHO) estimates that 15 million babies are delivered preterm each year (before 37 full weeks of pregnancy), and the number is growing. In 184 countries, preterm birth rates vary from 5% to 18%. Premature babies require more frequent feedings with adequate nutrition because they have a limited supply of both energy and nutrients. To guarantee that these infants receive the optimum nutrition, nasogastric tubes are used. In light of the growing number of sick and premature infants, the nasogastric tube industry is expected to grow considerably over the next few years.
On the other hand, the dysphagia segment held 20.5% of the nasogastric tube industry share in 2023, accounting for the largest share of the market. The WHO estimates that there are 15 million strokes per year around the world, resulting in 6 million fatalities and another 6 million disabilities like eye loss and speech impediment. As a result, the global market is expanding and nasogastric tube demand is increasing due to the growing prevalence of stroke-related dysphagia as well as related pharyngeal and laryngeal issues. Thus, propelling the market growth.
Type Insights
The small-bore feeding tube segment held the largest share of the market in 2023. It is also expected to witness the fastest growth from the 2023 to 2033 period. A small-bore feeding tube is introduced to allow access to the gastrointestinal tract for patients who are unable to ingest enough calories orally. The tube is capable of being utilized to deliver nutrients, fluids, and medicines. Thus, demand for these tubes increases among the patient population and end-users.
Additionally, small-bore feeding tubes are preferred during critical disease because they reduce the chance of tissue necrosis in the nares & sinusitis. There is a lower chance of pneumonia and vomiting when small-bore feeding tubes are implanted postpylorically. Thus, it will drive market growth.
End-use Insights
The hospital segment held the largest share of the market in 2023, with a 60.0% share. The growing incidence of ingestion & gastrointestinal issues among the aging population is the main reason propelling the hospital segment. When such cases occur, essential nutrients need to be supplemented via the nasogastric route, which positively impacts the requirement for nasogastric tube feeding. The segmental growth is also being fueled by the growing elderly population, the rising prevalence of chronic illnesses, and rising hospitalizations in various regions around the globe.
Additionally, geriatric patients are more prone to digestive issues and are more likely to need nasogastric tubes for management or therapy. Therefore, the demand for nasogastric tubes in the homecare setting is increased; this is anticipated to fuel the nasogastric tube industry's expansion.
Regional Insights
North America accounted for the largest share of the nasogastric tube industry in 2023, with 38.0%. The North American region is expected to exhibit high demand during the forecast period due to the development of various regulatory guidelines in the region. For example, the U.S. FDA released guidelines in June 2021 for testing the appropriateness of oral pharmaceutical drugs for enteral feeding tube application. These advancements drive the requirement of efficient nasogastric tubes, which may be needed for the maintenance of sufficient nutrition for a variety of reasons, including cancer, swallowing trouble, severe genetic or acquired neurological dysfunction, and other diseases.
The Asia Pacific region is expected to see profitable growth during the forecast period due to high unmet needs for digestive disease care facilities, as well as growing patient awareness levels about such facilities across the region, particularly in developing countries such as India, China, and Indonesia, which will boost product demand over the forecast period.
Some of the prominent players in the nasogastric tube market include:
Segments Covered in the Report
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Nova one advisor, Inc. has segmented the global nasogastric tube market.
Patient Type
Indication
Type
End-Use
By Region
Cross-segment Market Size and Analysis for Mentioned Segments
Additional Company Profiles
(Upto 5 With No Cost)
Additional Countries (Apart
From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers